Sven Zimmermann
CHIEF FINANCIAL OFFICER
finance
Novimmune SA
Switzerland
Biography
Sven Zimmermann joined Novimmune in September 2016 with over 15 years of both scientific and business experience in the biopharma industry. Sven previously held the position of CFO at Auris Medical AG (IPO on NASDAQ) and PregLem SA (acquired by Gedeon Richter Plc.). Prior to that, Sven was European Biotech analyst at UBS Investment Bank and is a board member of Epiontis GmbH. Sven holds a PhD in Molecular Biology from the University of Zurich.
Research Interest
finanace,Accounting & Marketing,Stock & Forex Trading
